Results 341 to 350 of about 199,652 (389)
Some of the next articles are maybe not open access.

Vascular disease in progressive systemic sclerosis (scleroderma).

Annals of Internal Medicine, 1970
Not only is the cause of progressive systemic sclerosis unknown, but there is no general agreement on the point of pathological impact.
W. L. Norton, J. Nardo
semanticscholar   +1 more source

Ischaemic stroke in progressive systemic sclerosis

Neurological Sciences, 2004
Progressive systemic sclerosis (PSS) or scleroderma is a multisystem disease affecting the skin, lungs, myocardium, kidneys and gastrointestinal tract. Primary involvement of cerebral arteries in PSS has been reported but is very rare. A 61-year-old woman suffering from scleroderma for six years was hospitalised for two subsequent episodes of transient
LUCIVERO V   +5 more
openaire   +3 more sources

Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma.

Arthritis & Rheumatism, 1979
Skin biopsies of uniform location and surface area (7 mm diameter) were obtained from the extensor aspect of the forearm of 147 patients with progressive systemic sclerosis (PSS) (107 with diffuse scleroderma, 40 with the CREST syndrome variant) and 58 ...
G. Rodnan, Esther Lipinski, J. Luksick
semanticscholar   +1 more source

SEROLOGICAL CHANGES IN PROGRESSIVE SYSTEMIC SCLEROSIS

Rheumatology, 1976
Sera from 37 patients with scleroderma were studied for the presence of auto-antibodies. Rheumatoid factors and antibodies to smooth muscle and thyroid were seen in some patients. Ten of 31 patients (32%) had antibodies to nuclear antigens. They were not related to the extent or severity of disease but were often associated with other complications or ...
M. I. V. Jayson, P. Davis
openaire   +3 more sources

Association of myositis and myocarditis in progressive systemic sclerosis.

Arthritis & Rheumatism, 1981
A retrospective review of 47 patients with progressive systemic sclerosis revealed a highly significant (P less than 0.001) association between myositis and myocarditis.
Sterling G. West   +2 more
semanticscholar   +1 more source

Trigeminal neuropathy in progressive systemic sclerosis

The American Journal of Medicine, 1982
Trigeminal neuropathy was identified in 16 (4 percent) of 442 consecutive patients with progressive systemic sclerosis (PSS) who were first evaluated during the period between 1972 and 1980. These cases, together with 25 others that are adequately documented in the literature, were reviewed and compared with the 426 cases of PSS (96 percent) without ...
Dorothy A. Farrell, Thomas A. Medsger
openaire   +3 more sources

Mesenchymal Stem Cell–Based Therapy as a New Approach for the Treatment of Systemic Sclerosis

Clinical reviews in allergy and immunology, 2022
X. Zhuang   +5 more
semanticscholar   +1 more source

Neurologic Manifestations of Progressive Systemic Sclerosis

Archives of Neurology, 1992
Neurologic involvement in progressive systemic sclerosis is considered uncommon. We retrospectively examined the prevalence and nature of neurologic complications in 50 patients with progressive systemic sclerosis. In 20 (40%), neurologic abnormalities were detected, with a total of 28 neurologic manifestations. All levels of the central and peripheral
Oded Abramsky   +2 more
openaire   +2 more sources

Progressive Systemic Sclerosis: Visceral Manifestations in Generalized Scleroderma

, 1955
The visceral manifestations of scleroderma have been recognized for almost 60 years, but the relative infrequency of the disease and the difficulty of obtaining adequate pathological material have, with certain outstanding exceptions, precluded the ...
W. Piper, E. B. Helwig
semanticscholar   +1 more source

Progressive Systemic Sclerosis (Scleroderma)

Postgraduate Medicine, 1962
The term “progressive systemic sclerosis” is preferred to “scleroderma,” since the skin is not always involved at first and rarely is not involved at all, even in fatal cases. Organic involvement is widespread. There is no satisfactory treatment, but there are measures which moderate the inexorable and fatal course of the disease, and certainly ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy